Insider · CIK 0001476315

Neumayer Matthew Paul

Reports to the SEC for 1 company · COLUMBIA, MD

sec.gov

Transactions

Companies

Filings

CIK

0001476315

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2014-09-30	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)D Disposition to Issuer	Principal Accounting Officer	DDisposition to Issuer	−1,000 sh	$7.13	−$7,130	4,375
2014-09-30	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)D Disposition to Issuer	Principal Accounting Officer	DDisposition to Issuer	−1,750 sh	$5.08	−$8,890	2,625
2014-09-30	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)D Disposition to Issuer	Principal Accounting Officer	DDisposition to Issuer	−2,625 sh	$7.73	−$20.3K	0
2013-08-20	OSIRIS THERAPEUTICS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+2,000 sh	$7.13	+$14.3K	2,000
2013-08-20	OSIRIS THERAPEUTICS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+1,500 sh	$6.46	+$9,690	3,500
2013-08-20	OSIRIS THERAPEUTICS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+3,000 sh	$7.74	+$23.2K	6,500
2013-08-20	OSIRIS THERAPEUTICS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+4,000 sh	$16.75	+$67K	10,500
2013-08-20	OSIRIS THERAPEUTICS, INC.M Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	+875 sh	$5.08	+$4,445	11,375
2013-08-20	OSIRIS THERAPEUTICS, INC.S Sale	Principal Accounting Officer	SSale	−11.4K sh	$19.75	−$225K	0
2013-08-20	OSIRIS THERAPEUTICS, INC.Incentive Stock Options, right to buyM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−2,000 sh	$7.13	−$14.3K	19,000
2013-08-20	OSIRIS THERAPEUTICS, INC.Incentive Stock Options, right to buyM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−1,500 sh	$6.46	−$9,690	17,500
2013-08-20	OSIRIS THERAPEUTICS, INC.Incentive stock options, right to buyM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−3,000 sh	$7.74	−$23.2K	14,500
2013-08-20	OSIRIS THERAPEUTICS, INC.Incentive stock option, right to buyM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−4,000 sh	$16.75	−$67K	10,500
2013-08-20	OSIRIS THERAPEUTICS, INC.Incentive stock option, right to buyM Exercise/Conversion	Principal Accounting Officer	MExercise/Conversion	−875 sh	$5.08	−$4,445	9,625
2013-02-12	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)A Award	Principal Accounting Officer	AAward	+3,500 sh	$7.73	+$27.1K	21,000
2012-03-23	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)A Award	Principal Accounting Officer	AAward	+3,500 sh	$5.08	+$17.8K	17,500
2011-02-14	OSIRIS THERAPEUTICS, INC.Incentive Stock Option (right to buy)A Award	Principal Accounting Officer	AAward	+4,000 sh	$7.13	+$28.5K	14,000
2010-05-27	OSIRIS THERAPEUTICS, INC.Incentive Stock OptionA Award	Principal Accounting Officer	AAward	+2,000 sh	$6.46	+$12.9K	10,000
2010-03-12	OSIRIS THERAPEUTICS, INC.Incentive Stock OptionA Award	Principal Accounting Officer	AAward	+4,000 sh	$7.74	+$31K	8,000

Recent filings

Accepted (ET)
Oct 24
OSIRIS THERAPEUTICS, INC.0001179110-14-014805
SEC(opens sec.gov)
Aug 204
OSIRIS THERAPEUTICS, INC.0001179110-13-013312
SEC(opens sec.gov)
Feb 134
Neumayer Matthew Paul0001179110-13-002641
SEC(opens sec.gov)
Mar 274
Neumayer Matthew Paul0001179110-12-005805
SEC(opens sec.gov)
Feb 164
Neumayer Matthew Paul0001179110-11-002824
SEC(opens sec.gov)
Jun 14
Neumayer Matthew Paul0001179110-10-009644
SEC(opens sec.gov)
Mar 164
Neumayer Matthew Paul0001179110-10-005401
SEC(opens sec.gov)

Companies

OSIRIS THERAPEUTICS, INC.Principal Accounting Officer

Address

OSIRIS THERAPEUTICS, INC. 7015 ALBERT EINSTEIN DRIVE

COLUMBIA, MD, 21046